Keros Therapeutics, Inc. (KROS)
16.20
-0.35
(-2.11%)
USD |
NASDAQ |
Feb 20, 16:00
16.21
+0.01
(+0.06%)
After-Hours: 20:00
Keros Therapeutics Market Cap : 493.55M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.499B |
| MannKind Corp. | 1.701B |
| Sarepta Therapeutics, Inc. | 1.978B |
| Insmed, Inc. | 35.17B |
| Ionis Pharmaceuticals, Inc. | 13.47B |
Market Cap Related Metrics
| PE Ratio | 10.50 |
| PS Ratio | 2.669 |
| Price to Book Value | 0.7015 |
| Price to Free Cash Flow | 7.562 |
| Price | 16.20 |
| Earnings Yield | 9.52% |
| Operating PE Ratio | 15.11 |
| Normalized PE Ratio | 10.50 |